Skip to main content
. 2022 Mar 31;27(13):2100540. doi: 10.2807/1560-7917.ES.2022.27.13.2100540

Figure 2.

Reported side effects in the first (n = 223,872) and second dose (n = 150,057) surveys after COVID-19 vaccination with Comirnaty, Israel, December 2020–March 2021

COVID-19: coronavirus disease.

Participants could indicate multiple symptoms. Proportions were weighted by age group and sex to make the sample representative of the general vaccinated population in the Maccabi Healthcare Services.

Figure 2